Search

Your search keyword '"Shepard, Dale"' showing total 258 results

Search Constraints

Start Over You searched for: Author "Shepard, Dale" Remove constraint Author: "Shepard, Dale"
258 results on '"Shepard, Dale"'

Search Results

51. Contributors

52. Contributors

54. Abstract CT031: COM701 demonstrates preliminary antitumor activity as monotherapy and in combination with nivolumab in patients with advanced solid tumors

56. A phase I study evaluating COM701 monotherapy and in combination with nivolumab in patients with advanced solid malignancies.

61. MOESM2 of A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors

62. Colaboradores

64. A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors

67. Abstract A011: First-in-man clinical trial of intratumoral injection of Clostridiumnovyi-NT spores in patients with treatment-refractory advanced solid tumors: Safety, activity, and immune responses

71. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

72. A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors

73. An open-label expanded-access study to evaluate the safety, tolerability, and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and hepatic impairment.

74. Axitinib plus crizotinib in patients with advanced solid tumors and metastatic renal cell carcinoma (mRCC): Preliminary phase 1b results.

75. Radiation Therapy in the Management of Soft Tissue Sarcoma

76. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

77. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016

80. Prospective Clinical Study of Precision Oncology in Solid Tumors

81. A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.

84. Prospective clinical study of precision oncology in solid tumors.

85. Phase II study evaluating the effect of concomitant ramucirumab (RAM) on the pharmacokinetics (PK) of irinotecan (IRI) and its metabolite SN-38 when coadministered with folinic acid (FA) and 5-fluorouracil (5-FU) (FOLFIRI) in patients (pts) with advanced malignant solid tumors.

89. Phase II study evaluating the effect of concomitant ramucirumab (IMC-1121B; RAM) on the pharmacokinetics (PK) of paclitaxel (PTX) and the PK of RAM as monotherapy in patients (pts) with advanced malignant solid tumors.

99. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

100. Curious grouse

Catalog

Books, media, physical & digital resources